Company intelligence / Profile preview

ImmunoRestoration

Warminster/Doylestown*, Pennsylvania, United Statesimmunorestoration.com ↗

Ownership: Private
Employees: ~9
Development stage: Other

Overview

ImmunoRestoration’s dendritic cell-based vaccines have shown promising efficacy in early clinical trials for breast cancer, with higher efficacy than some existing treatments based on Phase I and II data. The company is expanding into multi-center trials focused on DCIS and continues to develop additional indications. Ir-Vax is currently in Phase I for HER2-negative breast cancer. A Phase II trial combining their DC1 vaccine with paclitaxel, trastuzumab, and pertuzumab is ongoing in patients with HER2-positive disease.

Therapeutic areas: Oncology
Modalities: Dendritic cell vaccineTherapeutic vaccineCell therapy
Industry: Biotech

Drug pipeline

5 assets

ICAIT DC Vaccine (Melanoma)

Preclinical

4 more assets in the full pipeline.

Request access →

Partnerships

University of PennsylvaniaMoffitt Cancer CenterPennies in ActionThe Werner and Mary Henle Foundation

Beyond the preview

Go deeper on ImmunoRestoration.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ImmunoRestoration.

Explore the full profile